Perioperative Complications and Myocardial Injury Risk in Arthoplasty Patients Suspected of Having Obstructive Sleep Apnea
Perioperative Obstructive Sleep Apnea Intervention Study
1 other identifier
observational
100
1 country
1
Brief Summary
Obstructive Sleep Apnea (OSA) is a common and under-diagnosed breathing disorder characterized by recurrent partial or complete collapse of the upper airway (tongue, soft palate) during sleep. It causes recurrent episodes of asphyxia (suffocation) resulting in fragmented sleep, low blood oxygen levels (hypoxemia), and high carbon dioxide concentrations. Untreated OSA is associated with serious heart/lung and metabolic diseases including strokes, diabetes, and heart attacks. When a patient with OSA undergoes surgery, the symptoms of OSA are exacerbated afterwards due to the effects of anesthesia and related medications such as those used for pain control. This puts patients at higher risk for complications and necessitates nursing care and monitoring that are resource intensive. In many hospitals, patients with an OSA diagnosis are monitored after surgery in "high acuity" wards where the nurse to patient ratio is higher than usual. These high acuity/monitored beds are often in high demand, and their unavailability may sometimes mean cancellation of surgery or prolonged patient stay in the Post-operative Recovery Room, further causing operating room backlog. Another serious issue is that many patients do not know they actually have the OSA condition. It is estimated that up to 20% (1) of people in the general public have OSA and that 75% (2) of them are not diagnosed. When someone with OSA goes for surgery without previously being diagnosed, special precautions in care and monitoring may not be in place, until a complication develops. For this reason, this population - those most susceptible to have OSA, but with no previous formal testing for the condition - is the most at risk for complications, and is the target group for this trial. We plan to identify the study population by screening for OSA using the STOP-BANG questionnaire. Those who score high on this 8 item screening test have high likelihood of actually having OSA if they were to undergo formal testing and diagnosis in a Sleep Lab. We will identify cardio-respiratory complications by conducting a chart review and determine whether admission to a "high acuity" bed had any impact. As OSA patients are at higher risk for cardiovascular complications at baseline and around the time of surgery, blood test for troponin will be performed on post-op day 1 and 2 to investigate the rate of myocardial injury. With the rate of MINS (myocardial injury after non-cardiac surgery) reported to be 8% with almost 10% 30 day mortality (per VISION trial), this pilot project which focuses on arthroplasty patients with suspected OSA, will inform us of the arthroplasty surgery specific MINS risk for comparison.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2017
CompletedFirst Posted
Study publicly available on registry
September 13, 2017
CompletedStudy Start
First participant enrolled
December 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 12, 2018
CompletedMarch 18, 2019
March 1, 2019
8 months
September 11, 2017
March 14, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Composite Adverse Events
The incidence of adverse events (each listed as a secondary outcome) related to OSA combined as a composite end point
0-96 hours
Troponin
Testing for risk of MINS (myocardial injury after non-cardiac surgery)
Post-op Day 1
Troponin
Testing for risk of MINS (myocardial injury after non-cardiac surgery)
Post-op Day 2
Secondary Outcomes (9)
Respiratory or Cardiac Arrest
0-96 hours
Respiratory Therapy beyond standard nasal prong oxygen
0-96 hours
Pneumonia
0-96 hours
Naloxone Usage
0-96 hours
Airway Intervention for any cause
0-96 hours
- +4 more secondary outcomes
Other Outcomes (1)
30 Day Mortality
30 days
Study Arms (1)
Suspected OSA Patients Undergoing Knee or Hip Arthroplasty
These 100 subjects will be cared for and monitored in hospital following current hospital protocol. No change or intervention is to be administered. Troponin testing will be done post-op with other routine blood work.
Eligibility Criteria
Patients referred to the UBC Hospital to have knee/hip arthroplasty surgery.
You may qualify if:
- Patients undergoing elective primary or revision knee/hip replacement surgery.
- Patients with no previous OSA diagnosis (by polysomnography), who score \>=5 on STOP-BANG OSA screening.
You may not qualify if:
- Patients without ability to communicate in English by reading or writing.
- Patients with renal failure.
- Patients on CPAP therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UBC Hospital
Vancouver, British Columbia, Canada
Related Publications (2)
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013 May 1;177(9):1006-14. doi: 10.1093/aje/kws342. Epub 2013 Apr 14.
PMID: 23589584BACKGROUNDPunjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008 Feb 15;5(2):136-43. doi: 10.1513/pats.200709-155MG.
PMID: 18250205BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
September 11, 2017
First Posted
September 13, 2017
Study Start
December 4, 2017
Primary Completion
August 1, 2018
Study Completion
October 12, 2018
Last Updated
March 18, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share